Passive immunization with monoclonal antibodies against PrP [21], [35] or the creation of transgenic mice expressing antibodies against PrP [22], provide effective protection against transmissible spongiform encephalopathies, offering proof of principle for prophylaxis. Here, PRNP is linked to human prion disease.